Covenant Multifamily Offices’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Covenant Multifamily Offices's PFE Position: Q3 2021 in Review
Covenant Multifamily Offices reduced its Pfizer (PFE) stake by 5.7% in Q3 2021, selling an estimated $182K and leaving 68,081 shares worth $2.88M. The position accounts for 0.52% of the portfolio, ranked #30.
Covenant Multifamily Offices first reported a position in PFE in Q2 2019 and has held it in 10 quarters since. The position peaked at $2.89M in Q4 2019. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- Covenant Multifamily Offices held 68,081 shares of Pfizer worth $2.88M as of Q3 2021.
- Covenant Multifamily Offices sold 4,119 Pfizer shares in Q3 2021, an estimated $182K.
- Pfizer made up 0.52% of Covenant Multifamily Offices's portfolio in Q3 2021, its #30 holding.
- Covenant Multifamily Offices first reported a position in Pfizer in Q2 2019 and has held it in 10 quarters since.
- Covenant Multifamily Offices's Pfizer position peaked at $2.89M in Q4 2019.
- 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.